Literature DB >> 11790856

Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer.

C Arnerlöv1, S O Emdin, S Cajander, N O Bengtsson, B Tavelin, G Roos.   

Abstract

To study intratumoral DNA ploidy heterogeneity and S-phase fraction (SPF) variability, we prospectively collected five different samples from 48 breast carcinomas and each sample was analysed separately by flow cytometry. Aneuploidy rate was 89.6% after analysis of four or five samples. DNA ploidy heterogeneity, i.e., different samples classified as either DNA euploid or DNA aneuploid in the same tumor was seen in 17%, and DNA index heterogeneity, i.e., tumor populations with different DNA indices (DIs) seen in different samples was 44%. A statistical model defining SPF heterogeneity is proposed. SPF heterogeneity as defined by us was 71%, and as expected the SPF heterogeneity rate increased significantly with increasing number of analysed samples. Four or more samples are needed to detect the most deviant (highest) SPF values. An unrecognized intratumor heterogeneity of DNA ploidy and SPF may partly explain the conflicting results reported in the literature on the above prognostic indicators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11790856      PMCID: PMC4618211          DOI: 10.1155/2001/430674

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  12 in total

1.  Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.

Authors:  S John Weroha; Wilma L Lingle; Yan Hong; Sara Antonia Li; Jonathan J Li
Journal:  Horm Cancer       Date:  2010-02-10       Impact factor: 3.869

2.  Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats.

Authors:  Jonathan J Li; S John Weroha; Wilma L Lingle; Dan Papa; Jeffrey L Salisbury; Sara Antonia Li
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

3.  Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.

Authors:  Bhupendra Singh; Sarah M Mense; Nimee K Bhat; Sandeep Putty; William A Guthiel; Fabrizio Remotti; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-22       Impact factor: 4.219

4.  MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.

Authors:  Bhupendra Singh; Amruta M Ronghe; Anwesha Chatterjee; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2013-03-14       Impact factor: 4.944

5.  Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.

Authors:  Sarah M Mense; Bhupendra Singh; Fabrizio Remotti; Xinhua Liu; Hari K Bhat
Journal:  Carcinogenesis       Date:  2009-04-30       Impact factor: 4.944

6.  Microarray analysis of gene expression of mouse hepatocytes of different ploidy.

Authors:  Pin Lu; Sandrine Prost; Helen Caldwell; Jonathan D Tugwood; Graham R Betton; David J Harrison
Journal:  Mamm Genome       Date:  2007-08-29       Impact factor: 2.957

7.  Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.

Authors:  Bhupendra Singh; Rivka Shoulson; Anwesha Chatterjee; Amruta Ronghe; Nimee K Bhat; Daniel C Dim; Hari K Bhat
Journal:  Carcinogenesis       Date:  2014-06-03       Impact factor: 4.944

8.  Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure.

Authors:  Sarah M Mense; Fabrizio Remotti; Ashima Bhan; Bhupendra Singh; Mahmoud El-Tamer; Tom K Hei; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-01       Impact factor: 4.219

9.  Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.

Authors:  Bhupendra Singh; Sarah M Mense; Fabrizio Remotti; Xinhua Liu; Hari K Bhat
Journal:  J Biochem Mol Toxicol       Date:  2009 May-Jun       Impact factor: 3.642

10.  Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Anwesha Chatterjee; Amruta M Ronghe; Nimee K Bhat; Hari K Bhat
Journal:  BMC Cancer       Date:  2013-05-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.